KR19990087687A - Process for preparing fluorinated aromatics and fluorinated nitrogen-containing hetero-aromatics - Google Patents
Process for preparing fluorinated aromatics and fluorinated nitrogen-containing hetero-aromatics Download PDFInfo
- Publication number
- KR19990087687A KR19990087687A KR1019980707152A KR19980707152A KR19990087687A KR 19990087687 A KR19990087687 A KR 19990087687A KR 1019980707152 A KR1019980707152 A KR 1019980707152A KR 19980707152 A KR19980707152 A KR 19980707152A KR 19990087687 A KR19990087687 A KR 19990087687A
- Authority
- KR
- South Korea
- Prior art keywords
- formula
- compound
- radicals
- alkyl
- same
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- -1 fluorinated nitrogen-containing hetero-aromatics Chemical class 0.000 title claims description 8
- 238000004519 manufacturing process Methods 0.000 title claims description 5
- 150000001875 compounds Chemical class 0.000 claims abstract description 106
- 238000000034 method Methods 0.000 claims abstract description 36
- 150000002367 halogens Chemical group 0.000 claims abstract description 30
- 239000012429 reaction media Substances 0.000 claims abstract description 28
- 229910052731 fluorine Inorganic materials 0.000 claims abstract description 25
- 229910052801 chlorine Inorganic materials 0.000 claims abstract description 24
- 229910052794 bromium Inorganic materials 0.000 claims abstract description 23
- 229910052736 halogen Inorganic materials 0.000 claims abstract description 23
- 239000011737 fluorine Substances 0.000 claims abstract description 15
- 150000001491 aromatic compounds Chemical class 0.000 claims abstract description 12
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 claims abstract 3
- 229910052739 hydrogen Inorganic materials 0.000 claims description 35
- 239000001257 hydrogen Substances 0.000 claims description 35
- 125000003118 aryl group Chemical group 0.000 claims description 27
- 229910052757 nitrogen Inorganic materials 0.000 claims description 20
- 238000006467 substitution reaction Methods 0.000 claims description 20
- 239000002904 solvent Substances 0.000 claims description 19
- 229910004013 NO 2 Inorganic materials 0.000 claims description 18
- 238000003682 fluorination reaction Methods 0.000 claims description 18
- 150000002431 hydrogen Chemical class 0.000 claims description 18
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 17
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 17
- 229910052740 iodine Inorganic materials 0.000 claims description 10
- 239000007858 starting material Substances 0.000 claims description 10
- 238000009835 boiling Methods 0.000 claims description 9
- 125000004432 carbon atom Chemical group C* 0.000 claims description 9
- 239000003085 diluting agent Substances 0.000 claims description 8
- 125000000896 monocarboxylic acid group Chemical group 0.000 claims description 8
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 5
- 239000000654 additive Substances 0.000 claims description 5
- KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 claims description 4
- 125000003710 aryl alkyl group Chemical group 0.000 claims description 4
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims description 4
- 229910052792 caesium Inorganic materials 0.000 claims description 4
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 4
- 125000001072 heteroaryl group Chemical group 0.000 claims description 4
- 229910052700 potassium Inorganic materials 0.000 claims description 4
- 229910052701 rubidium Inorganic materials 0.000 claims description 4
- 229910052708 sodium Inorganic materials 0.000 claims description 4
- 230000000996 additive effect Effects 0.000 claims description 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 3
- 239000002609 medium Substances 0.000 claims description 2
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims 1
- 238000006243 chemical reaction Methods 0.000 abstract description 24
- 230000015572 biosynthetic process Effects 0.000 abstract description 5
- 239000006227 byproduct Substances 0.000 abstract description 3
- 238000003786 synthesis reaction Methods 0.000 abstract description 2
- 239000013543 active substance Substances 0.000 abstract 1
- 150000002222 fluorine compounds Chemical class 0.000 abstract 1
- 239000013067 intermediate product Substances 0.000 abstract 1
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 32
- 230000000052 comparative effect Effects 0.000 description 28
- 239000000460 chlorine Substances 0.000 description 25
- YCKRFDGAMUMZLT-UHFFFAOYSA-N Fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 description 15
- 239000000047 product Substances 0.000 description 13
- 239000011698 potassium fluoride Substances 0.000 description 12
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 9
- 239000011541 reaction mixture Substances 0.000 description 9
- WFQDTOYDVUWQMS-UHFFFAOYSA-N 1-fluoro-4-nitrobenzene Chemical compound [O-][N+](=O)C1=CC=C(F)C=C1 WFQDTOYDVUWQMS-UHFFFAOYSA-N 0.000 description 8
- CZGCEKJOLUNIFY-UHFFFAOYSA-N 4-Chloronitrobenzene Chemical compound [O-][N+](=O)C1=CC=C(Cl)C=C1 CZGCEKJOLUNIFY-UHFFFAOYSA-N 0.000 description 8
- 239000003054 catalyst Substances 0.000 description 8
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- BFCFYVKQTRLZHA-UHFFFAOYSA-N 1-chloro-2-nitrobenzene Chemical compound [O-][N+](=O)C1=CC=CC=C1Cl BFCFYVKQTRLZHA-UHFFFAOYSA-N 0.000 description 5
- LOTKRQAVGJMPNV-UHFFFAOYSA-N 1-fluoro-2,4-dinitrobenzene Chemical compound [O-][N+](=O)C1=CC=C(F)C([N+]([O-])=O)=C1 LOTKRQAVGJMPNV-UHFFFAOYSA-N 0.000 description 5
- PWKNBLFSJAVFAB-UHFFFAOYSA-N 1-fluoro-2-nitrobenzene Chemical compound [O-][N+](=O)C1=CC=CC=C1F PWKNBLFSJAVFAB-UHFFFAOYSA-N 0.000 description 5
- VYZAHLCBVHPDDF-UHFFFAOYSA-N Dinitrochlorobenzene Chemical compound [O-][N+](=O)C1=CC=C(Cl)C([N+]([O-])=O)=C1 VYZAHLCBVHPDDF-UHFFFAOYSA-N 0.000 description 5
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 description 5
- HXJUTPCZVOIRIF-UHFFFAOYSA-N sulfolane Chemical compound O=S1(=O)CCCC1 HXJUTPCZVOIRIF-UHFFFAOYSA-N 0.000 description 5
- SVWHXFUUCAUJSN-UHFFFAOYSA-N 1-methyl-1$l^{5}-phospholane 1-oxide Chemical compound CP1(=O)CCCC1 SVWHXFUUCAUJSN-UHFFFAOYSA-N 0.000 description 4
- IUUONVQOMMQAEH-UHFFFAOYSA-N 1-methyl-2,3-dihydro-1$l^{5}-phosphole 1-oxide Chemical compound CP1(=O)CCC=C1 IUUONVQOMMQAEH-UHFFFAOYSA-N 0.000 description 4
- MQLQAXIVFGHSDE-UHFFFAOYSA-N 1-methyl-2,5-dihydro-1$l^{5}-phosphole 1-oxide Chemical compound CP1(=O)CC=CC1 MQLQAXIVFGHSDE-UHFFFAOYSA-N 0.000 description 4
- DPVIABCMTHHTGB-UHFFFAOYSA-N 2,4,6-trichloropyrimidine Chemical compound ClC1=CC(Cl)=NC(Cl)=N1 DPVIABCMTHHTGB-UHFFFAOYSA-N 0.000 description 4
- NTSYSQNAPGMSIH-UHFFFAOYSA-N 2,4,6-trifluoropyrimidine Chemical compound FC1=CC(F)=NC(F)=N1 NTSYSQNAPGMSIH-UHFFFAOYSA-N 0.000 description 4
- FHQWUIZMJXPGRG-UHFFFAOYSA-N 3,5-dichloro-2-fluoropyridine Chemical compound FC1=NC=C(Cl)C=C1Cl FHQWUIZMJXPGRG-UHFFFAOYSA-N 0.000 description 4
- PERMDYZFNQIKBL-UHFFFAOYSA-N 5-chloro-2,3-difluoropyridine Chemical compound FC1=CC(Cl)=CN=C1F PERMDYZFNQIKBL-UHFFFAOYSA-N 0.000 description 4
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 4
- 239000002202 Polyethylene glycol Substances 0.000 description 4
- XJHCXCQVJFPJIK-UHFFFAOYSA-M cesium fluoride Substances [F-].[Cs+] XJHCXCQVJFPJIK-UHFFFAOYSA-M 0.000 description 4
- 229920001223 polyethylene glycol Polymers 0.000 description 4
- NROKBHXJSPEDAR-UHFFFAOYSA-M potassium fluoride Chemical compound [F-].[K+] NROKBHXJSPEDAR-UHFFFAOYSA-M 0.000 description 4
- QUIMTLZDMCNYGY-UHFFFAOYSA-N 2,4-dichloro-1-nitrobenzene Chemical compound [O-][N+](=O)C1=CC=C(Cl)C=C1Cl QUIMTLZDMCNYGY-UHFFFAOYSA-N 0.000 description 3
- RJXOVESYJFXCGI-UHFFFAOYSA-N 2,4-difluoro-1-nitrobenzene Chemical compound [O-][N+](=O)C1=CC=C(F)C=C1F RJXOVESYJFXCGI-UHFFFAOYSA-N 0.000 description 3
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 3
- 239000002585 base Substances 0.000 description 3
- JFDZBHWFFUWGJE-UHFFFAOYSA-N benzonitrile Chemical compound N#CC1=CC=CC=C1 JFDZBHWFFUWGJE-UHFFFAOYSA-N 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000004508 fractional distillation Methods 0.000 description 3
- 125000005843 halogen group Chemical class 0.000 description 3
- GNOIPBMMFNIUFM-UHFFFAOYSA-N hexamethylphosphoric triamide Chemical compound CN(C)P(=O)(N(C)C)N(C)C GNOIPBMMFNIUFM-UHFFFAOYSA-N 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 238000010626 work up procedure Methods 0.000 description 3
- AZUYLZMQTIKGSC-UHFFFAOYSA-N 1-[6-[4-(5-chloro-6-methyl-1H-indazol-4-yl)-5-methyl-3-(1-methylindazol-5-yl)pyrazol-1-yl]-2-azaspiro[3.3]heptan-2-yl]prop-2-en-1-one Chemical compound ClC=1C(=C2C=NNC2=CC=1C)C=1C(=NN(C=1C)C1CC2(CN(C2)C(C=C)=O)C1)C=1C=C2C=NN(C2=CC=1)C AZUYLZMQTIKGSC-UHFFFAOYSA-N 0.000 description 2
- YSFBEAASFUWWHU-UHFFFAOYSA-N 2,4-dichlorobenzaldehyde Chemical compound ClC1=CC=C(C=O)C(Cl)=C1 YSFBEAASFUWWHU-UHFFFAOYSA-N 0.000 description 2
- WCGPCBACLBHDCI-UHFFFAOYSA-N 2,4-difluorobenzaldehyde Chemical compound FC1=CC=C(C=O)C(F)=C1 WCGPCBACLBHDCI-UHFFFAOYSA-N 0.000 description 2
- PZASAAIJIFDWSB-CKPDSHCKSA-N 8-[(1S)-1-[8-(trifluoromethyl)-7-[4-(trifluoromethyl)cyclohexyl]oxynaphthalen-2-yl]ethyl]-8-azabicyclo[3.2.1]octane-3-carboxylic acid Chemical compound FC(F)(F)C=1C2=CC([C@@H](N3C4CCC3CC(C4)C(O)=O)C)=CC=C2C=CC=1OC1CCC(C(F)(F)F)CC1 PZASAAIJIFDWSB-CKPDSHCKSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 2
- KAKZBPTYRLMSJV-UHFFFAOYSA-N Butadiene Chemical compound C=CC=C KAKZBPTYRLMSJV-UHFFFAOYSA-N 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 150000003983 crown ethers Chemical class 0.000 description 2
- 239000012043 crude product Substances 0.000 description 2
- 238000006731 degradation reaction Methods 0.000 description 2
- 238000005265 energy consumption Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- XYFCBTPGUUZFHI-UHFFFAOYSA-O phosphonium Chemical compound [PH4+] XYFCBTPGUUZFHI-UHFFFAOYSA-O 0.000 description 2
- 235000003270 potassium fluoride Nutrition 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 230000035484 reaction time Effects 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- PUZPDOWCWNUUKD-UHFFFAOYSA-M sodium fluoride Chemical compound [F-].[Na+] PUZPDOWCWNUUKD-UHFFFAOYSA-M 0.000 description 2
- NHGXDBSUJJNIRV-UHFFFAOYSA-M tetrabutylammonium chloride Chemical compound [Cl-].CCCC[N+](CCCC)(CCCC)CCCC NHGXDBSUJJNIRV-UHFFFAOYSA-M 0.000 description 2
- USFPINLPPFWTJW-UHFFFAOYSA-N tetraphenylphosphonium Chemical compound C1=CC=CC=C1[P+](C=1C=CC=CC=1)(C=1C=CC=CC=1)C1=CC=CC=C1 USFPINLPPFWTJW-UHFFFAOYSA-N 0.000 description 2
- AYGPGZLSTYWDGO-UHFFFAOYSA-N 1,2-dichlorobenzene;hydrofluoride Chemical compound F.ClC1=CC=CC=C1Cl AYGPGZLSTYWDGO-UHFFFAOYSA-N 0.000 description 1
- XKEFYDZQGKAQCN-UHFFFAOYSA-N 1,3,5-trichlorobenzene Chemical compound ClC1=CC(Cl)=CC(Cl)=C1 XKEFYDZQGKAQCN-UHFFFAOYSA-N 0.000 description 1
- BLWGKIXZAUOECS-UHFFFAOYSA-N 1,3-dichloro-5-fluorobenzene Chemical compound FC1=CC(Cl)=CC(Cl)=C1 BLWGKIXZAUOECS-UHFFFAOYSA-N 0.000 description 1
- IHCJMWMYDKMWRQ-UHFFFAOYSA-N 1-(2-methylpropyl)-1$l^{5}-phospholane 1-oxide Chemical compound CC(C)CP1(=O)CCCC1 IHCJMWMYDKMWRQ-UHFFFAOYSA-N 0.000 description 1
- JQHODWCUIPNJHB-UHFFFAOYSA-N 1-(2-methylpropyl)-2,3-dihydro-1lambda5-phosphole 1-oxide Chemical compound C(C(C)C)P1(CCC=C1)=O JQHODWCUIPNJHB-UHFFFAOYSA-N 0.000 description 1
- DZMXPKSHYXUTKB-UHFFFAOYSA-N 1-(2-methylpropyl)-2,5-dihydro-1lambda5-phosphole 1-oxide Chemical compound C(C(C)C)P1(CC=CC1)=O DZMXPKSHYXUTKB-UHFFFAOYSA-N 0.000 description 1
- KRRVNCXPBSPLFM-UHFFFAOYSA-N 1-butan-2-yl-1lambda5-phospholane 1-oxide Chemical compound C(C)(CC)P1(CCCC1)=O KRRVNCXPBSPLFM-UHFFFAOYSA-N 0.000 description 1
- OLNHPNCMMYSCLK-UHFFFAOYSA-N 1-butan-2-yl-2,3-dihydro-1lambda5-phosphole 1-oxide Chemical compound C(C)(CC)P1(CCC=C1)=O OLNHPNCMMYSCLK-UHFFFAOYSA-N 0.000 description 1
- LAESBUJZZLKYFR-UHFFFAOYSA-N 1-butan-2-yl-2,5-dihydro-1lambda5-phosphole 1-oxide Chemical compound C(C)(CC)P1(CC=CC1)=O LAESBUJZZLKYFR-UHFFFAOYSA-N 0.000 description 1
- WZAIFYLOAIJCQP-UHFFFAOYSA-N 1-butyl-1$l^{5}-phospholane 1-oxide Chemical compound CCCCP1(=O)CCCC1 WZAIFYLOAIJCQP-UHFFFAOYSA-N 0.000 description 1
- JSGWRKKVZHFMPZ-UHFFFAOYSA-N 1-butyl-2,3-dihydro-1$l^{5}-phosphole 1-oxide Chemical compound CCCCP1(=O)CCC=C1 JSGWRKKVZHFMPZ-UHFFFAOYSA-N 0.000 description 1
- ORQSXMYVZRGWNX-UHFFFAOYSA-N 1-butyl-2,5-dihydro-1$l^{5}-phosphole 1-oxide Chemical compound CCCCP1(=O)CC=CC1 ORQSXMYVZRGWNX-UHFFFAOYSA-N 0.000 description 1
- CXCZAONHMWAJEG-UHFFFAOYSA-N 1-ethyl-1$l^{5}-phospholane 1-oxide Chemical compound CCP1(=O)CCCC1 CXCZAONHMWAJEG-UHFFFAOYSA-N 0.000 description 1
- IOSIDVPNBKUUFA-UHFFFAOYSA-N 1-ethyl-2,3-dihydro-1$l^{5}-phosphole 1-oxide Chemical compound CCP1(=O)CCC=C1 IOSIDVPNBKUUFA-UHFFFAOYSA-N 0.000 description 1
- QNNSUQVWGWYCCH-UHFFFAOYSA-N 1-ethyl-2,5-dihydro-1$l^{5}-phosphole 1-oxide Chemical compound CCP1(=O)CC=CC1 QNNSUQVWGWYCCH-UHFFFAOYSA-N 0.000 description 1
- JJANPEKPJRSTDL-UHFFFAOYSA-N 1-hexyl-2,3-dihydro-1lambda5-phosphole 1-oxide Chemical compound C(CCCCC)P1(CCC=C1)=O JJANPEKPJRSTDL-UHFFFAOYSA-N 0.000 description 1
- ZXDQSIBPBIVFPI-UHFFFAOYSA-N 1-hexyl-2,5-dihydro-1lambda5-phosphole 1-oxide Chemical compound C(CCCCC)P1(CC=CC1)=O ZXDQSIBPBIVFPI-UHFFFAOYSA-N 0.000 description 1
- VRLYFBLWNDHJRW-UHFFFAOYSA-N 1-octyl-1$l^{5}-phospholane 1-oxide Chemical compound CCCCCCCCP1(=O)CCCC1 VRLYFBLWNDHJRW-UHFFFAOYSA-N 0.000 description 1
- KJYZQWKFSGJUGS-UHFFFAOYSA-N 1-pentyl-1$l^{5}-phospholane 1-oxide Chemical compound CCCCCP1(=O)CCCC1 KJYZQWKFSGJUGS-UHFFFAOYSA-N 0.000 description 1
- IDNBGCGTWDNUQO-UHFFFAOYSA-N 1-pentyl-2,3-dihydro-1$l^{5}-phosphole 1-oxide Chemical compound CCCCCP1(=O)CCC=C1 IDNBGCGTWDNUQO-UHFFFAOYSA-N 0.000 description 1
- OVLWKFRJUVVBLV-UHFFFAOYSA-N 1-pentyl-2,5-dihydro-1lambda5-phosphole 1-oxide Chemical compound C(CCCC)P1(CC=CC1)=O OVLWKFRJUVVBLV-UHFFFAOYSA-N 0.000 description 1
- ZTMYLZNVTQHHFF-UHFFFAOYSA-N 1-phenoxy-1$l^{5}-phospholane 1-oxide Chemical compound C=1C=CC=CC=1OP1(=O)CCCC1 ZTMYLZNVTQHHFF-UHFFFAOYSA-N 0.000 description 1
- QHKMQMHWPKMPEG-UHFFFAOYSA-N 1-propan-2-yl-1$l^{5}-phospholane 1-oxide Chemical compound CC(C)P1(=O)CCCC1 QHKMQMHWPKMPEG-UHFFFAOYSA-N 0.000 description 1
- PDFHZFPEIQIEIZ-UHFFFAOYSA-N 1-propan-2-yl-2,3-dihydro-1lambda5-phosphole 1-oxide Chemical compound C(C)(C)P1(CCC=C1)=O PDFHZFPEIQIEIZ-UHFFFAOYSA-N 0.000 description 1
- LUUUBKDJFQEHPV-UHFFFAOYSA-N 1-propan-2-yl-2,5-dihydro-1lambda5-phosphole 1-oxide Chemical compound C(C)(C)P1(CC=CC1)=O LUUUBKDJFQEHPV-UHFFFAOYSA-N 0.000 description 1
- YDODGSKXWLOKLE-UHFFFAOYSA-N 1-propyl-1$l^{5}-phospholane 1-oxide Chemical compound CCCP1(=O)CCCC1 YDODGSKXWLOKLE-UHFFFAOYSA-N 0.000 description 1
- RMWORNHHZMHKJD-UHFFFAOYSA-N 1-propyl-2,3-dihydro-1$l^{5}-phosphole 1-oxide Chemical compound CCCP1(=O)CCC=C1 RMWORNHHZMHKJD-UHFFFAOYSA-N 0.000 description 1
- IBZGTQUHVYHUHT-UHFFFAOYSA-N 1-propyl-2,5-dihydro-1lambda5-phosphole 1-oxide Chemical compound C(CC)P1(CC=CC1)=O IBZGTQUHVYHUHT-UHFFFAOYSA-N 0.000 description 1
- CBNBKYAMGMJGSE-UHFFFAOYSA-N 1-tert-butyl-1$l^{5}-phospholane 1-oxide Chemical compound CC(C)(C)P1(=O)CCCC1 CBNBKYAMGMJGSE-UHFFFAOYSA-N 0.000 description 1
- XEZNGIUYQVAUSS-UHFFFAOYSA-N 18-crown-6 Chemical compound C1COCCOCCOCCOCCOCCO1 XEZNGIUYQVAUSS-UHFFFAOYSA-N 0.000 description 1
- HBJPCBYDFZOSOT-UHFFFAOYSA-N 2,5-dichloropyridin-4-amine Chemical compound NC1=CC(Cl)=NC=C1Cl HBJPCBYDFZOSOT-UHFFFAOYSA-N 0.000 description 1
- OTZQYBFTOANOJO-UHFFFAOYSA-N 2-chloro-1,3-difluorobenzene Chemical compound FC1=CC=CC(F)=C1Cl OTZQYBFTOANOJO-UHFFFAOYSA-N 0.000 description 1
- RSHVNOSVXPLXLO-UHFFFAOYSA-N 5-chloro-2-fluoropyridin-4-amine Chemical compound NC1=CC(F)=NC=C1Cl RSHVNOSVXPLXLO-UHFFFAOYSA-N 0.000 description 1
- QUIROEVQMYXIDM-UHFFFAOYSA-N C(C(C)(C)C)P1(CCCC1)=O Chemical compound C(C(C)(C)C)P1(CCCC1)=O QUIROEVQMYXIDM-UHFFFAOYSA-N 0.000 description 1
- NNYYODQMNLBBSR-UHFFFAOYSA-N C(C)N(P1(CCCC1)=O)CC Chemical compound C(C)N(P1(CCCC1)=O)CC NNYYODQMNLBBSR-UHFFFAOYSA-N 0.000 description 1
- UNSRNIJTLJRRSY-UHFFFAOYSA-N C(CCCCC)P1(CCCC1)=O Chemical compound C(CCCCC)P1(CCCC1)=O UNSRNIJTLJRRSY-UHFFFAOYSA-N 0.000 description 1
- KLBHHSQPWMXAAM-UHFFFAOYSA-N C(CCCCCC)P1(CCCC1)=O Chemical compound C(CCCCCC)P1(CCCC1)=O KLBHHSQPWMXAAM-UHFFFAOYSA-N 0.000 description 1
- MXPTYPDEVFKQDV-UHFFFAOYSA-N CN(P1(CCCC1)=O)C Chemical compound CN(P1(CCCC1)=O)C MXPTYPDEVFKQDV-UHFFFAOYSA-N 0.000 description 1
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 1
- QLWRPCACLLFFDT-UHFFFAOYSA-N FC(C=CC=C1)=C1Cl.F Chemical compound FC(C=CC=C1)=C1Cl.F QLWRPCACLLFFDT-UHFFFAOYSA-N 0.000 description 1
- 208000033962 Fontaine progeroid syndrome Diseases 0.000 description 1
- OKIZCWYLBDKLSU-UHFFFAOYSA-M N,N,N-Trimethylmethanaminium chloride Chemical compound [Cl-].C[N+](C)(C)C OKIZCWYLBDKLSU-UHFFFAOYSA-M 0.000 description 1
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical class C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 125000001309 chloro group Chemical group Cl* 0.000 description 1
- 229960001701 chloroform Drugs 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 239000007857 degradation product Substances 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- VVRKSAMWBNJDTH-UHFFFAOYSA-N difluorophosphane Chemical compound FPF VVRKSAMWBNJDTH-UHFFFAOYSA-N 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 239000012025 fluorinating agent Substances 0.000 description 1
- 238000004817 gas chromatography Methods 0.000 description 1
- 238000002290 gas chromatography-mass spectrometry Methods 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000012263 liquid product Substances 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- MOVBJUGHBJJKOW-UHFFFAOYSA-N methyl 2-amino-5-methoxybenzoate Chemical compound COC(=O)C1=CC(OC)=CC=C1N MOVBJUGHBJJKOW-UHFFFAOYSA-N 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 235000019645 odor Nutrition 0.000 description 1
- 150000007530 organic bases Chemical class 0.000 description 1
- 150000004714 phosphonium salts Chemical class 0.000 description 1
- 239000002798 polar solvent Substances 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 150000003222 pyridines Chemical class 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 235000013024 sodium fluoride Nutrition 0.000 description 1
- 239000011775 sodium fluoride Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- 238000010189 synthetic method Methods 0.000 description 1
- CZDYPVPMEAXLPK-UHFFFAOYSA-N tetramethylsilane Chemical compound C[Si](C)(C)C CZDYPVPMEAXLPK-UHFFFAOYSA-N 0.000 description 1
- GEPYJHDOGKHEMZ-UHFFFAOYSA-M tetraphenylphosphanium;fluoride Chemical compound [F-].C1=CC=CC=C1[P+](C=1C=CC=CC=1)(C=1C=CC=CC=1)C1=CC=CC=C1 GEPYJHDOGKHEMZ-UHFFFAOYSA-M 0.000 description 1
- WAGFXJQAIZNSEQ-UHFFFAOYSA-M tetraphenylphosphonium chloride Chemical compound [Cl-].C1=CC=CC=C1[P+](C=1C=CC=CC=1)(C=1C=CC=CC=1)C1=CC=CC=C1 WAGFXJQAIZNSEQ-UHFFFAOYSA-M 0.000 description 1
- 230000008646 thermal stress Effects 0.000 description 1
- YTWOHSWDLJUCRK-UHFFFAOYSA-N thiolane 1,1-dioxide Chemical compound O=S1(=O)CCCC1.O=S1(=O)CCCC1 YTWOHSWDLJUCRK-UHFFFAOYSA-N 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 239000002351 wastewater Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B39/00—Halogenation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C201/00—Preparation of esters of nitric or nitrous acid or of compounds containing nitro or nitroso groups bound to a carbon skeleton
- C07C201/06—Preparation of nitro compounds
- C07C201/12—Preparation of nitro compounds by reactions not involving the formation of nitro groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
- C07C45/63—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by introduction of halogen; by substitution of halogen atoms by other halogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/61—Halogen atoms or nitro radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/42—One nitrogen atom
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyridine Compounds (AREA)
Abstract
반응 매질중에서 플루오라이드(예: KF)를 사용하여 할로겐 교환에 의해 화학식 I의 상응하는 Cl 또는 Br-함유 화합물로부터 화학식 I의 플루오르화 방향족 화합물을 제조하는 방법이 공지되어 있다. 본 발명에 따라, "할렉스" 반응(할로겐을 불소로 치환)이 화학식 III, IV 및/또는 V의 화합물을 함유하는 반응 매질에서 수행된다. 이 방법은 보다 온화한 조건에 적용될 수 있고 생산량이 많고 부산물이 보다 적은 특히 유리한 방법을 제공한다. 화학식 I의 플루오르화 방향족 화합물은, 예를 들어 활성 제제의 합성을 위한 중간체 생성물로서 사용된다.It is known to produce fluorinated aromatic compounds of formula (I) from the corresponding Cl or Br-containing compounds of formula (I) by halogen exchange using fluorides (eg KF) in the reaction medium. According to the invention, a "halex" reaction (substituting halogen with fluorine) is carried out in a reaction medium containing a compound of formula III, IV and / or V. This method can be applied to milder conditions and provides a particularly advantageous method with higher yields and fewer byproducts. Fluorinated aromatic compounds of formula I are used, for example, as intermediate products for the synthesis of active agents.
화학식 IFormula I
화학식 IIIFormula III
화학식 IVFormula IV
화학식 VFormula V
상기식에서,In the above formula,
W, X, Z, R1, R2및 R16내지 R24는 발명의 상세한 설명에 제시된 의미를 가진다.W, X, Z, R 1 , R 2 and R 16 to R 24 have the meanings given in the detailed description of the invention.
Description
본 발명은 하기 화학식 I의 화합물에 상응하지만 화학식 I에서 불소인 라디칼 R1내지 R6중의 하나가 Cl 또는 Br인 화합물을 반응 매질에서 화학식 II의 플루오라이드와 반응시켜 화학식 I의 플루오르화 방향족 화합물을 제조하는 방법에 관한 것이다:The present invention corresponds to a compound of formula (I), but reacting a compound wherein one of the radicals R 1 to R 6 which is fluorine in formula (I) is Cl or Br with a fluoride of formula (II) in a reaction medium to Relates to a method of making:
상기식에서,In the above formula,
W는 N 또는 CR3이고,W is N or CR 3 ,
X는 N 또는 CR4이며,X is N or CR 4 ,
Y는 N 또는 CR5이고,Y is N or CR 5 ,
Z는 N 또는 CR6이며,Z is N or CR 6 ,
R1, R2, R3, R4, R5및 R6은 동일하거나 상이하고, 수소, F, Cl, Br, I, NO2, CF3, CN, CHO, COF, SO2F, SO2Cl, OCF3, SCF3, SO2CF3, COOR7, CONR8R9, SO2R10, COR11또는 OR12이거나, 서로에 대해 오르토 위치에 존재하고 그룹 R1내지 R6로부터 유래하는 2개의 라디칼은 함께 -OC-NR13-CO-이고,R 1 , R 2 , R 3 , R 4 , R 5 and R 6 are the same or different and hydrogen, F, Cl, Br, I, NO 2 , CF 3 , CN, CHO, COF, SO 2 F, SO 2 Cl, OCF 3 , SCF 3 , SO 2 CF 3 , COOR 7 , CONR 8 R 9 , SO 2 R 10 , COR 11 or OR 12, or are in the ortho position relative to one another and derived from groups R 1 to R 6 The two radicals together are —OC—NR 13 —CO—,
R7, R8, R9, R10, R11, R12및 R13은 동일하거나 상이하고, 서로 독립적으로 수소, 직쇄 또는 측쇄의 C1내지 C6-알킬, 아릴, 바람직하게는 페닐, 또는 아릴알킬이고, 알킬 라디칼 및 아릴알킬 라디칼은 적합한 경우 할로겐에 의해 3회 이하로 치환될 수 있으며, 바람직하게는 CF3및 CHalXH3-X이며,R 7 , R 8 , R 9 , R 10 , R 11 , R 12 and R 13 are the same or different and independently from each other hydrogen, straight or branched C 1 to C 6 -alkyl, aryl, preferably phenyl, Or arylalkyl, the alkyl radical and the arylalkyl radical may be substituted up to three times by halogen if appropriate, preferably CF 3 and CHal X H 3-X ,
라디칼 R1내지 R13중의 2개 이상은 적합한 경우 서로 연결되어 하나 이상의 3 내지 7원 환을 형성하고,Two or more of the radicals R 1 to R 13 are suitably linked to one another to form one or more three to seven membered rings,
단, (i) W, X 및 Y는 동시에 N이 아니고;Provided that (i) W, X and Y are not N at the same time;
(ii) 라디칼 R1내지 R6중의 하나 이상은 불소이어야 하며;(ii) at least one of the radicals R 1 to R 6 must be fluorine;
(iii) a) 화학식 I의 화합물이 방향족 단핵 할로겐화 화합물인 경우, 그룹 R1내지 R6의 나머지 라디칼중 하나 이상은 NO2, CF3, CN, CHO, COOH, COCl, COF, SO2F, SO2Cl, SO2CF3, CONR8R9, SO2R10또는 COR11이고;(iii) a) when the compound of formula (I) is an aromatic mononuclear halogenated compound, at least one of the remaining radicals of groups R 1 to R 6 is NO 2 , CF 3 , CN, CHO, COOH, COCl, COF, SO 2 F, SO 2 Cl, SO 2 CF 3 , CONR 8 R 9 , SO 2 R 10 or COR 11 ;
b) 화학식 I의 화합물이 바람직하게는 방향족 핵상에 3개의 할로겐 치환체를 갖는 방향족 다핵 할로겐화 화합물인 경우, 그룹 R1내지 R6의 나머지 라디칼은 모두 수소일 수 있으며;b) when the compound of formula (I) is preferably an aromatic multinuclear halogenated compound having three halogen substituents on the aromatic nucleus, all remaining radicals of groups R 1 to R 6 may be hydrogen;
Me는 Na, K, Cs, Rb, N(R14)4또는 P(R15)4이고,Me is Na, K, Cs, Rb, N (R 14 ) 4 or P (R 15 ) 4 ,
4개의 라디칼 R14는 서로 독립적으로 동일하거나 상이할 수 있고, 수소 또는 직쇄 또는 측쇄의 C1내지 C8-알킬(여기서, 알킬 라디칼은 예를 들어 방향족 라디칼에 의해 치환될 수 있다)이며, 4개의 라디칼 R15는 서로 독립적으로 동일하거나 상이할 수 있고, R14와 동일하거나 페닐일 수 있다.The four radicals R 14 may be the same or different independently of one another and are hydrogen or straight or branched C 1 to C 8 -alkyl, wherein the alkyl radicals may for example be substituted by aromatic radicals, 4 Radicals R 15 may independently be the same or different and may be the same as R 14 or be phenyl.
방향족 결합된 수소를 불소로 치환하는 것은 생활성 물질의 합성 및 이러한 화합물의 전구체의 제조에 매우 중요하다. 또한, 불소가 생물학적 활성의 화학적 화합물에 대해 강력하고 종종 예기치 못한 효과를 나타낸다는 것도 공지되어 있다. 생물학적 활성 분자내에서 수소를 불소로 치환하면, 종종 증가되거나 변형된 생물학적 효과를 갖는 동족체 화합물이 생성된다.Substitution of aromatic bonded hydrogen with fluorine is very important for the synthesis of bioactive materials and for the preparation of precursors of such compounds. It is also known that fluorine exhibits potent and often unexpected effects on biologically active chemical compounds. Substitution of hydrogen with fluorine in biologically active molecules often results in homologue compounds with increased or modified biological effects.
직접적인 플루오르화 이외에, 할로겐(Cl, Br)을 불소로 치환하여 불소-함유 방향족 화합물을 제조(소위 "할렉스 방법(halex process)")하는 것은 산업상 매우 중요한 극히 유용한 반응이다.In addition to direct fluorination, the substitution of halogens (Cl, Br) with fluorine to produce fluorine-containing aromatic compounds (the so-called "halex process") is an extremely useful reaction of great industrial importance.
본 기술분야와 가장 밀접히 관련되는 문헌을 언급하면 다음과 같다:References to literature most closely related to the art include:
D1 = Finger et al., J. Am. Chem. Soc. 87(1965) 430,D1 = Finger et al., J. Am. Chem. Soc. 87 (1965) 430,
D2 = DE-A 27 24 367,D2 = DE-A 27 24 367,
D3 = EP-A-0 164 619,D3 = EP-A-0 164 619,
D4 = Dmowski et al., J. Fluor. Chem., 41(2) (1988) 241,D4 = Dmowski et al., J. Fluor. Chem., 41 (2) (1988) 241,
D5 = Banks et al., J. Fluor. Chem., 46(1990) 529,D5 = Banks et al., J. Fluor. Chem., 46 (1990) 529,
D6 = Clark et al., Tetrahedron Lett., 28(1987), 111,D6 = Clark et al., Tetrahedron Lett., 28 (1987), 111,
D7 = Deutsch et al., Synth. Chem., 55(1991), 335,D7 = Deutsch et al., Synth. Chem., 55 (1991), 335,
D8 = JP-A-87 105 097,D8 = JP-A-87 105 097,
D9 = JP-A-90 83 364,D9 = JP-A-90 83 364,
D10 = Pews et al., J. Fluor., Chem., 50(1990) 365ff.,D10 = Pews et al., J. Fluor., Chem., 50 (1990) 365ff.,
D11 = CA 105: 60401c 내지 JP 61 50 945,D11 = CA 105: 60401c to JP 61 50 945,
D12 = CA 104: 129611v 내지 JP 60 237 051,D12 = CA 104: 129611v to JP 60 237 051,
D13 = CA 115: 135672j 내지 JP 03 077-850 A,D13 = CA 115: 135672j to JP 03 077-850 A,
D14 =CA 109: 92482d 내지 DE 36 37 156 및D14 = CA 109: 92482d to DE 36 37 156 and
D15 = CA 113: 175049b 내지 JP 02 111-624.D15 = CA 113: 175049b to JP 02 111-624.
상기 특허 및 특허 공보 D1 내지 D5는 일반적인 방법으로 KF, CsF 또는 (알크)4N+F-를 사용한 할로겐 원자의 직접적인 치환에 의한 불소-함유 방향족 화합물의 제조방법을 기술하고 있다. 그럼에도 불구하고, CsF 또는 (알크)4N+F-의 높은 비용으로 인해, 현재 산업상 이용하고 있는 것은 단지 KF뿐이다. 그러나, 이러한 화합물의 이용은 많은 중대한 단점을 안고 있다.The patents and patent publications D1 to D5 describe the preparation of fluorine-containing aromatic compounds by direct substitution of halogen atoms using KF, CsF or (alk) 4 N + F − in a general manner. Nevertheless, due to the high cost of CsF or (alk) 4 N + F − , only KF is currently used in industry. However, the use of such compounds has many significant disadvantages.
일반적으로, 대부분의 비양자성 유기 용매에서 KF의 용해도는 매우 낮고, 약 10-3mol/l 이하의 범위이다. 이것은 용액내에서 저농도의 플루오라이드 이온을 나타내고, 사실상 장기간의 반응 시간, 높은 에너지 소비 및 높은 장치 비용을 유도한다. 또한, 고온을 사용하여야 하며, 종종 결과적으로 분산물의 형성을 유도할 수 있다.In general, the solubility of KF in most aprotic organic solvents is very low and ranges up to about 10 −3 mol / l. This results in low concentrations of fluoride ions in solution and in fact leads to long reaction times, high energy consumption and high equipment costs. In addition, high temperatures must be used, often resulting in the formation of dispersions.
Cl→F 치환은 활성화된 방향족 화합물의 경우에 약 100 내지 200℃ 및 비-활성화된 방향족 화합물의 경우에 약 250 내지 400℃의 온도 범위에서 통상적으로 발생한다. 특히, 활성적이지 않거나 단지 약간만 활성적인 방향족 화합물의 경우에는 현저한 반응 조건(예: D10)이 요구되고, 다수의 부산물이 형성된다. 이러한 반응은 용매의 존재 또는 부재하에 수행될 수 있다. 그러나, 최상의 결과는 반응 매질로서 비양자성의 고도의 극성 용매가 사용되는 경우에 달성된다.Cl → F substitutions typically occur in a temperature range of about 100 to 200 ° C. for activated aromatic compounds and about 250 to 400 ° C. for non-activated aromatic compounds. In particular, for aromatic compounds which are not active or only slightly active, significant reaction conditions (eg D10) are required and a large number of by-products are formed. This reaction can be carried out in the presence or absence of a solvent. However, best results are achieved when aprotic, highly polar solvents are used as the reaction medium.
용매로서는 아세토니트릴(CH3CN), 디메틸포름아미드(DMFA), 디메틸아세트아미드(DMAA), N-메틸피롤리돈-(NMP), 디메틸 설폭사이드(DMSO), 테트라메틸렌설폰(설폴란 또는 TMS), 헥사메틸포스포릭 트리아미드(HMPA), 피리딜니트릴(PyrCN) 또는 벤조니트릴(PhCN)이 사용된다.Examples of solvents include acetonitrile (CH 3 CN), dimethylformamide (DMFA), dimethylacetamide (DMAA), N-methylpyrrolidone- (NMP), dimethyl sulfoxide (DMSO), tetramethylenesulfone (sulfolane or TMS ), Hexamethylphosphoric triamide (HMPA), pyridylnitrile (PyrCN) or benzonitrile (PhCN) is used.
낮은 비점(각각 80 내지 150℃)으로 인해, CH3CN 및 DMFA만이 고도로 활성화된 할로겐 원자를 치환시키는데 적합하다. 높은 수율의 불소-함유 생성물은 종종 무기염의 용해력이 현저한 것으로 공지된 DMSO를 용매로서 사용하는 경우 달성된다. 그러나, DMSO의 낮은 열 안정성은 (CH3)2S 및 (CH3)SO2로의 분해를 유도한다. 이들 분해 생성물은 분해에 수반되는, 가능한 피하여야 하는 불쾌한 냄새를 유발한다.Due to the low boiling point (80-150 ° C. respectively), only CH 3 CN and DMFA are suitable for replacing highly activated halogen atoms. High yields of fluorine-containing products are often achieved when using DMSO as a solvent, which is known to have significant solubility of inorganic salts. However, the low thermal stability of DMSO leads to degradation into (CH 3 ) 2 S and (CH 3 ) SO 2 . These degradation products cause unpleasant odors that should be avoided, possibly accompanied by degradation.
원칙적으로, 동일한 기제를 사용하는 경우, KF를 사용한 플루오르화 속도는 다음 방식으로 용매에 따라 증가한다:In principle, when using the same base, the rate of fluorination with KF increases with solvent in the following manner:
아세토니트릴(CH3CN)→N-메틸피롤리돈(NMP)→테트라메틸렌설폰(설폴란)→디메틸 설폭사이드(DMSO)(cf. D6).Acetonitrile (CH 3 CN) → N-methylpyrrolidone (NMP) → tetramethylenesulfone (sulfolane) → dimethyl sulfoxide (DMSO) (cf. D6).
(HMPA)는 할렉스 반응용 용매로서 현저한 특성을 나타내지만, 독성으로 인해 산업 공정에는 적합하지 않다.(HMPA) is a solvent for Harlex reactions but is not suitable for industrial processes due to its toxicity.
반응 혼합물에서 KF의 용해도를 증가시키고 상응하게 플루오르화 활성을 개선시키기 위해 다수의 촉매가 사용되어 왔다. 따라서, 문헌 D7은 크라운 에테르 또는 폴리에틸렌 글리콜(PEG)의 첨가를 권장하는 반면, 문헌 D8 및 D9는 각각 암모늄 염 및 포스포늄 염의 첨가를 제안한다. 그러나, 촉매의 첨가는 일반적으로 보다 높은 비용을 나타낸다. 또한, 폐수의 오염을 유발하고, 첨가된 촉매는 종종 만족할만 방식으로 촉매하지 않는다.Many catalysts have been used to increase the solubility of KF in the reaction mixture and to correspondingly improve the fluorination activity. Thus, Document D7 recommends the addition of crown ethers or polyethylene glycol (PEG), while Documents D8 and D9 suggest addition of ammonium salts and phosphonium salts, respectively. However, the addition of catalysts generally shows higher costs. In addition, it causes contamination of the waste water, and the added catalyst is often not catalyzed in a satisfactory manner.
본원에 제시 및 언급된 선행 문헌에 비추어, 본 발명의 목적은 전형적으로 상기에 언급되고 정의된 목적 화합물을 우수한 수율 및 고도의 선택성을 갖게 제조할 수 있는 방법을 명시하는 것이다. 본 발명의 신규한 방법은 대규모의 산업상 용도에 적합하고, 환경 오염을 가능한 최소화하며, 동시에 상대적으로 단순한 방법을 이용하여 경제적이도록 하는 것이다. 또한, 본 발명의 방법은 현재 본 기술 분야에서 이용할 수 있는 방법에 부수하여 특히 상술된 단점이 최대한 없도록 하는 것이다.In view of the prior documents presented and referred to herein, the object of the present invention is typically to specify a method by which the target compounds mentioned and defined above can be prepared with good yield and high selectivity. The novel method of the present invention is to be suitable for large scale industrial applications, to minimize environmental pollution as much as possible, and at the same time to be economical using a relatively simple method. In addition, the method of the present invention is directed to methods currently available in the art so that the above-mentioned disadvantages are in particular maximized.
본 발명의 목적, 및 상세히 명시되지 않은 다른 목적은 상기에 언급된 형태로 구성되고 청구항 1의 특정한 부분의 특징을 갖는 방법에 의해 달성된다.The object of the present invention, and other objects not specified in detail, are achieved by a method which is constructed in the form mentioned above and which has the features of a particular part of claim 1.
본 발명 방법의 편의상 변형도 청구항 1에 종속하는 종속 청구항에서 보호된다. 본 발명에 속하는 용도는 청구항 11 및 청구항 12의 대상이다.Modifications for convenience of the method of the invention are also protected in the dependent claims according to claim 1. Uses belonging to the invention are the subject of claims 11 and 12.
할로겐 치환에 의한 플루오르화가 화학식 III의 1-알킬-2,3-디하이드로-1H-포스폴-1-옥사이드, 화학식 IV의 1-알킬-2,5-디하이드로-1H-포스폴-1-옥사이드 및/또는 화학식 V의 1-알킬-포스폴란-1-옥사이드를 함유하는 반응 매질에서 수행된다는 사실에 기인하여, 수득된 반응 생성물의 선택성, 수율 및 성질과 관련하여 용이하게 예측할 수 없는 방식으로 공지된 방법을 개선시키는 방법을 제공하는 것이 특히 유리하게 달성된다:Fluorination by halogen substitution results in 1-alkyl-2,3-dihydro-1H-phosphol-1-oxide of formula III, 1-alkyl-2,5-dihydro-1H-phosphol-1- of formula IV Due to the fact that it is carried out in a reaction medium containing oxides and / or 1-alkyl-phospholan-1-oxides of the formula V, in an unpredictable manner in terms of the selectivity, yield and properties of the reaction product obtained It is particularly advantageous to provide a method for improving the known method:
상기식에서,In the above formula,
R16은 직쇄 또는 측쇄의 탄소수 1 내지 8의 알킬 라디칼, 페닐, 벤질, 사이클로알킬, OR25또는 NR26R27(여기서, R25내지 R27은 서로 독립적으로 동일하거나 상이하고, 직쇄 또는 측쇄의 탄소수 1 내지 4의 알킬 라디칼이다)이고,R 16 is straight or branched alkyl radical of 1 to 8 carbon atoms, phenyl, benzyl, cycloalkyl, OR 25 or NR 26 R 27 , wherein R 25 to R 27 are the same as or different from each other independently and are linear or branched Is an alkyl radical having 1 to 4 carbon atoms),
R17, R18, R19, R20, R21, R22, R23및 R24는 서로 독립적으로 동일하거나 상이하고, 수소, 페닐 또는 직쇄 또는 측쇄의 C1-8-알킬 라디칼이다.R 17 , R 18 , R 19 , R 20 , R 21 , R 22 , R 23 and R 24 are independently the same or different from each other and are hydrogen, phenyl or straight or branched C 1-8 -alkyl radicals.
놀랍게도, 본 발명에 이르러, 문헌에 자체로 공지된 화학식 III, IV 및/또는 V의 화합물의 용매로서의 이용이 반응을 강력히 가속화시킬 수 있고, 그 결과 할렉스 반응을 실질적으로 보다 저온에서, 및 결과적으로 이미 가능하였던 것보다 온화한 조건하에 수행할 수 있음이 밝혀졌다. 이것은 또한 부산물의 형성이 억제되거나 완전히 제거되도록 한다.Surprisingly, by the present invention, the use of the compounds of the formulas III, IV and / or V as known in the literature as solvents can strongly accelerate the reaction, resulting in the Halex reaction at substantially lower temperatures, and consequently It has been found that it can be carried out under milder conditions than already possible. This also allows the formation of byproducts to be suppressed or eliminated completely.
특히, 본 발명의 방법은 하기 장점을 나타낸다:In particular, the method of the present invention exhibits the following advantages:
화학식 III 내지 V의 화합물은 무독성이거나 극히 저독성이고, 비점이 높은 열적으로 안정한 액체이다.Compounds of Formulas III-V are nontoxic or extremely low toxicity, high thermally stable liquids.
동시에, 예를 들어 화학식 III 내지 V의 반응 매질에서 KF의 용해도는 특히 승온에서 TMS, NMP 또는 DMAA에서 보다 실질적으로 우수하고 DMSO의 용해도에 상당하여, 할로겐 치환에 의한 방향족 화합물의 플루오르화는 고도의 정교한 기술없이도 완성되며, 반응 시간 및 에너지 소비가 감소된다.At the same time, for example, the solubility of KF in the reaction medium of formulas III to V is substantially better than that of TMS, NMP or DMAA, especially at elevated temperatures and corresponds to the solubility of DMSO, so that fluorination of aromatic compounds by halogen substitution is highly Complete without sophisticated technology, reaction time and energy consumption are reduced.
이것 이외에, 열 스트레스에 견디는 화학식 III 내지 V의 화합물의 능력은 예를 들어 본 기술 분야에 공지되고 종종 사용되는 화합물인 DMSO의 능력보다 현저히 높다. 따라서, R17내지 R24가 수소이고 R16이 메틸인 화학식 V의 화합물이 사용되는 경우, 250℃에서 7일 후에 최대 1.4%의 탄소질 분해 생성물이 발견된다.In addition to this, the ability of the compounds of formulas III to V to withstand thermal stress is significantly higher than that of DMSO, for example, compounds known and often used in the art. Thus, when a compound of formula V is used wherein R 17 to R 24 are hydrogen and R 16 is methyl, up to 1.4% of carbonaceous decomposition products are found after 7 days at 250 ° C.
이러한 이유로 인해, 할렉스 반응용 반응 매질에 또는 반응 매질로서 화학식 III 내지 V의 화합물의 이용은 모두 환경적으로 친밀한 화학적 방법이다.For this reason, the use of the compounds of the formulas (III) to (V) in or as a reaction medium for the Harlex reaction are all environmentally friendly chemical methods.
마지막으로, 화학식 III 내지 V의 화합물은 광범위한 비점을 포함하며, 예측된 목적 생성물의 비점에 따라 적합한 화합물을 구체적으로 선택함으로써 반응 혼합물을 대부분의 경우에 플루오르화 이후에 반응 혼합물의 분별 증류에 의해 후처리할 수 있다.Finally, the compounds of the formulas III to V contain a wide range of boiling points, and the reaction mixture is in most cases after fractional distillation of the reaction mixture after fluorination, in particular by selecting a suitable compound according to the predicted boiling point of the desired product. Can be processed.
이들 수단에 의해, 또한 화학식 III 내지 V의 화합물을 분리하고, 경우에 따라 이들을 재순환시킬 수 있다.By these means, it is also possible to separate the compounds of the formulas III to V and optionally recycle them.
본 발명의 범위내에서, 화학식 III 내지 V의 화합물은 이들이 할렉스 반응용 반응 매질에 존재하는 경우, 즉 이들이 할로겐 치환에 의한 플루오르화를 위한 통상의 반응 매질을 구성하는 경우 이러한 잇점을 이미 제공할 수 있다. 본 발명의 잇점은 이러한 방식으로 달성될 수 있다. 이러한 맥락에서, 화학식 III 내지 V의 화합물의 비율은 소량의 첨가물이 할렉스 반응에 명확한 효과를 나타낼 수 있기 때문에 가변적이다. 본 발명에 따라 반응 매질에 존재하는 화학식 III 내지 V의 화합물의 비율은 화학식 I에 상응하지만 화학식 I에서 불소인 라디칼 R1내지 R6중의 하나가 Cl 또는 Br인 화합물을 기준으로 하여 바람직하게는 1.0 내지 100mol%, 특히 5.0 내지 80mol%, 및 특히 바람직하게는 10 내지 60mol%이다.Within the scope of the present invention, the compounds of the formulas (III) to (V) already provide these advantages when they are present in the reaction medium for the Halex reaction, i.e. when they constitute a conventional reaction medium for fluorination by halogen substitution. Can be. The advantages of the invention can be achieved in this way. In this context, the proportion of compounds of Formulas III-V is variable because small amounts of additives may have a definite effect on the Halex reaction. The proportion of compounds of the formulas (III) to (V) present in the reaction medium according to the invention corresponds to formula (I) but is preferably 1.0 based on compounds wherein one of the radicals R 1 to R 6 , which is fluorine in formula (I), is Cl or Br To 100 mol%, in particular 5.0 to 80 mol%, and particularly preferably 10 to 60 mol%.
반응 매질의 총 중량을 기준으로 하여 50중량%(wt/wt) 이상의 비율이 특히 편리하다.A ratio of at least 50% by weight (wt / wt) based on the total weight of the reaction medium is particularly convenient.
그러나, 특정한 방법의 변형에 있어서 할렉스 반응용 반응 매질로서는 화학식 Ⅲ의 1-알킬-2,3-디하이드로-1H-포스폴-1-옥사이드, 화학식 IV의 1-알킬-2,5-디하이드로-1H-포스폴-1-옥사이드 및/또는 화학식 V의 1-알킬-포스폴란-1-옥사이드를 사용하는 것이 바람직하다. 이것은 대부분의 반응 매질이 상기 화합물에 의해 형성된다는 것을 의미한다. 본 발명에 따른 잇점은 특히 현저하다. 본 명세서에서 미량의 다른 용매 또는 희석물을 제외하였으나, 이들은 소량으로 첨가될 수 있다(10중량% 미만(wt/wt)).However, in a variant of the specific method, the reaction medium for the Harlex reaction may be 1-alkyl-2,3-dihydro-1H-phosphol-1-oxide of formula III, 1-alkyl-2,5-di of formula IV. Preference is given to using hydro-1H-phosphol-1-oxide and / or 1-alkyl-phospholane-1-oxide of the formula (V). This means that most of the reaction medium is formed by the compound. The advantages according to the invention are particularly significant. Although a small amount of other solvents or dilutions are excluded herein, they may be added in small amounts (less than 10 wt% (wt / wt)).
본 발명에 따른 희석제 또는 용매로서 사용하기에 적합한 대다수의 화학식 Ⅲ의 1-알킬-2,3-디하이드로-1H-포스폴-1-옥사이드, 화학식 IV의 1-알킬-2,5-디하이드로-1H-포스폴-1-옥사이드 및/또는 화학식 V의 1-알킬-포스폴란-1-옥사이드는 상업적으로 수득하여 이용할 수 있다. 상업적으로 이용할 수 없는 화학식 III 내지 V의 화합물은 본 기술 분야의 통상의 지식을 가진 자에게 익숙한 방법을 사용하여 단순한 방식으로 합성할 수 있다. 합성 방법의 예는 특히 DE-A 28 26 621 또는 DE-A 35 14 451에 제공되어 있다.Most 1-alkyl-2,3-dihydro-1H-phosphol-1-oxides of formula III, 1-alkyl-2,5-dihydro of formula IV suitable for use as diluents or solvents according to the invention -1H-phosphole-1-oxide and / or 1-alkyl-phospholane-1-oxide of formula V can be obtained commercially and used. Compounds of formulas III to V that are not commercially available can be synthesized in a simple manner using methods familiar to those skilled in the art. Examples of synthetic methods are in particular provided in DE-A 28 26 621 or DE-A 35 14 451.
예를 들면, 부타디엔으로 출발하고 하기 반응식 1에 따라 진행시켜 1-메틸-2,5-디하이드로-1H-포스폴-1-옥사이드(화학식 IVa의 화합물)을 제조하는 것이 특히 바람직하다:For example, it is particularly preferred to prepare 1-methyl-2,5-dihydro-1H-phosphol-1-oxide (compound of Formula IVa) starting with butadiene and proceeding according to Scheme 1 below:
화학식 III 내지 V의 화합물을 제조하는 또 다른 예시적인 경로는 에틸렌 옥사이드로 출발한다(반응식 2).Another exemplary route for preparing compounds of Formulas III-V starts with ethylene oxide (Scheme 2).
이미 언급된 바와 같이, 상기 반응 매질은 희석제 또는 용매로서 또는 희석제 또는 용매에 대한 첨가제로서 사용될 수 있다. 신규한 화합물은 순수한 형태 또는 한가지 화합물 이상의 혼합물로서 사용될 수 있다.As already mentioned, the reaction medium can be used as a diluent or solvent or as an additive to a diluent or solvent. The novel compounds can be used in pure form or as mixtures of one or more compounds.
화학식 III 내지 V의 화합물에 포함되는 상이한 화합물은 상이한 비점을 갖는다. 방향족 출발 화합물 및 생성물의 비점에 따라 및 후처리되는 생성물에 따라, 제조된 화합물 또는 화학식 III 내지 V의 몇몇 화합물의 최적 혼합물이 다른 반응 매질에 대한 첨가제로서 또는 순수한 형태 또는 혼합물로서의 반응 매질로서 각각의 경우에 선택될 수 있다.Different compounds included in compounds of Formulas III-V have different boiling points. Depending on the boiling point of the aromatic starting compound and the product and the product to be worked up, the optimum mixture of the prepared compound or of several compounds of the formulas (III) to (V) may be prepared as additives to other reaction media or as reaction medium in pure form or as a mixture. May be selected in the case.
본 발명에 따라 바람직하게 사용될 수 있는 화합물은 특히 다음과 같다:Compounds which can preferably be used according to the invention are in particular as follows:
1-메틸-2,3-디하이드로-1H-포스폴-1-옥사이드;1-methyl-2,3-dihydro-1H-phosphol-1-oxide;
1-에틸-2,3-디하이드로-1H-포스폴-1-옥사이드;1-ethyl-2,3-dihydro-1H-phosphol-1-oxide;
1-n-프로필-2,3-디하이드로-1H-포스폴-1-옥사이드;1-n-propyl-2,3-dihydro-1H-phosphol-1-oxide;
1-이소프로필-2,3-디하이드로-1H-포스폴-1-옥사이드;1-isopropyl-2,3-dihydro-1H-phosphol-1-oxide;
1-n-부틸-2,3-디하이드로-1H-포스폴-1-옥사이드;1-n-butyl-2,3-dihydro-1H-phosphol-1-oxide;
1-이소부틸-2,3-디하이드로-1H-포스폴-1-옥사이드;1-isobutyl-2,3-dihydro-1H-phosphol-1-oxide;
1-2급-부틸-2,3-디하이드로-1H-포스폴-1-옥사이드;1-2-butyl-2,3-dihydro-1H-phosphol-1-oxide;
1-n-펜틸-2,3-디하이드로-1H-포스폴-1-옥사이드;1-n-pentyl-2,3-dihydro-1H-phosphol-1-oxide;
1-n-헥실-2,3-디하이드로-1H-포스폴-1-옥사이드;1-n-hexyl-2,3-dihydro-1H-phosphol-1-oxide;
1-메틸-2,5-디하이드로-1H-포스폴-1-옥사이드;1-methyl-2,5-dihydro-1H-phosphol-1-oxide;
1-에틸-2,5-디하이드로-1H-포스폴-1-옥사이드;1-ethyl-2,5-dihydro-1H-phosphol-1-oxide;
1-n-프로필-2,5-디하이드로-1H-포스폴-1-옥사이드;1-n-propyl-2,5-dihydro-1H-phosphol-1-oxide;
1-이소프로필-2,5-디하이드로-1H-포스폴-1-옥사이드;1-isopropyl-2,5-dihydro-1H-phosphol-1-oxide;
1-n-부틸-2,5-디하이드로-1H-포스폴-1-옥사이드;1-n-butyl-2,5-dihydro-1H-phosphol-1-oxide;
1-이소부틸-2,5-디하이드로-1H-포스폴-1-옥사이드;1-isobutyl-2,5-dihydro-1H-phosphol-1-oxide;
1-2급-부틸-2,5-디하이드로-1H-포스폴-1-옥사이드;1-2-butyl-2,5-dihydro-1H-phosphol-1-oxide;
1-n-펜틸-2,5-디하이드로-1H-포스폴-1-옥사이드;1-n-pentyl-2,5-dihydro-1H-phosphol-1-oxide;
1-n-헥실-2,5-디하이드로-1H-포스폴-1-옥사이드;1-n-hexyl-2,5-dihydro-1H-phosphol-1-oxide;
1-메틸포스폴란-1-옥사이드;1-methylphospholane-1-oxide;
1-에틸포스폴란-1-옥사이드;1-ethylphospholane-1-oxide;
1-n-프로필포스폴란-1-옥사이드;1-n-propylphospholane-1-oxide;
1-이소프로필포스폴란-1-옥사이드;1-isopropylphospholane-1-oxide;
1-n-부틸포스폴란-1-옥사이드;1-n-butylphospholane-1-oxide;
1-이소부틸포스폴란-1-옥사이드;1-isobutylphospholane-1-oxide;
1-2급-부틸포스폴란-1-옥사이드;1-2-butylphospholane-1-oxide;
1-3급-부틸포스폴란-1-옥사이드;Tert-butylphospholane-1-oxide;
1-n-펜틸포스폴란-1-옥사이드;1-n-pentylphospholane-1-oxide;
1-네오-펜틸포스폴란-1-옥사이드;1-neo-pentylphospholane-1-oxide;
1-n-헥실포스폴란-1-옥사이드;1-n-hexylphospholane-1-oxide;
1-n-헵틸포스폴란-1-옥사이드;1-n-heptylphospholane-1-oxide;
1-n-옥틸포스폴란-1-옥사이드;1-n-octylphospholane-1-oxide;
1-디메틸아미노포스폴란-1-옥사이드;1-dimethylaminophospholane-1-oxide;
1-디에틸아미노포스폴란-1-옥사이드, 및/또는1-diethylaminophospholane-1-oxide, and / or
1-페녹시포스폴란-1-옥사이드.1-phenoxyphospholane-1-oxide.
화학식 III 내지 V의 화합물중에서, 본 발명의 범위내에서 특히 바람직한 화합물은 1-메틸-2,3-디하이드로-1H-포스폴-1-옥사이드(화합물 IIIa와 동일), 1-메틸-2,5-디하이드로-1H-포스폴-1-옥사이드(화합물 IVa와 동일) 및/또는 1-메틸-포스폴란-1-옥사이드(화합물 Va와 동일)이고, 할로겐 치환에 의한 플루오르화는 R16이 메틸이고 R17내지 R24가 수소인 화학식 III, IV 및/또는 V의 하나 이상의 화합물내에서 수행된다.Among the compounds of the formulas III-V, particularly preferred compounds within the scope of the invention are 1-methyl-2,3-dihydro-1H-phosphol-1-oxide (same as compound IIIa), 1-methyl-2, 5-dihydro-1H-phosphol-1-oxide (same as compound IVa) and / or 1-methyl-phospholan-1-oxide (same as compound Va), and fluorination by halogen substitution is R 16 It is carried out in one or more compounds of formula III, IV and / or V wherein methyl and R 17 to R 24 are hydrogen.
특히 편리한 방식에 있어서, 신규한 방법은 할로겐 치환에 의한 플루오르화가 화학식 V의 1-알킬-포스폴란-1-옥사이드내에서 수행된다는 뜻으로 추가로 변형되며, 1-메틸-포스폴란-1-옥사이드(화합물 Va와 동일)이 특히 편리하다.In a particularly convenient manner, the new process is further modified in that the fluorination by halogen substitution is carried out in 1-alkyl-phospholane-1-oxide of formula V, and 1-methyl-phospholane-1-oxide (Same as compound Va) is particularly convenient.
신규한 방법은 화학식 I에 상응하는 다수의 화합물에 적용되며, 보다 큰 분자내에 방향족 아단위로서 화학식 I의 구조를 포함한다는 점에서 이들 기제가 또한 포함된다.The novel process applies to many of the compounds corresponding to formula (I), and these bases are also included in that they include the structure of formula (I) as aromatic subunits in larger molecules.
본 발명의 범위내에서, 화학식 VI의 화합물은 화학식 VII의 화합물로부터 편리하게 변형된 방법으로 제조한다:Within the scope of the present invention, compounds of formula VI are prepared by methods conveniently modified from compounds of formula VII:
상기식에서,In the above formula,
R1'내지 R5'는 동일하거나 상이하고, 수소, F, Cl, Br, I, NO2, CF3, CN, CHO, COF, SO2F, SO2Cl, OCF3, SCF3, SO2CF3, COOR7, CONR8R9, SO2R10, COR11또는 OR12이거나, 서로에 대해 오르토 위치에 존재하고 그룹 R1'내지 R5'으로부터 유래하는 2개의 라디칼은 함께 -OC-NR13-CO이고, R7내지 R13은 화학식 I과 동일하고, 화학식 VI의 화합물이 방향족 단핵 할로겐화 화합물인 경우 그룹 R1'내지 R5'의하나 이상의 라디칼은 NO2, CF3, CN, CHO, COOH, COCl, COF, SO2F, SO2Cl, SO2CF3, CONR8R9, SO2R10또는 COR11이며, 화학식 VI의 화합물이 바람직하게는 방향족 핵상에 3개의 할로겐 치환체를 갖는 방향족 다핵 할로겐화 화합물인 경우 그룹 R1'내지 R5'의 나머지 라디칼은 모두 수소일 수 있고,R 1 ' to R 5' are the same or different and are hydrogen, F, Cl, Br, I, NO 2 , CF 3 , CN, CHO, COF, SO 2 F, SO 2 Cl, OCF 3 , SCF 3 , SO 2 radicals which are 2 CF 3 , COOR 7 , CONR 8 R 9 , SO 2 R 10 , COR 11 or OR 12, or are in the ortho position with respect to each other and derived from groups R 1 ′ to R 5 ′ together are —OC -NR 13 -CO, R 7 to R 13 are the same as in Formula I, and when the compound of Formula VI is an aromatic mononuclear halogenated compound, at least one radical of groups R 1 ' to R 5' is NO 2 , CF 3 , CN , CHO, COOH, COCl, COF, SO 2 F, SO 2 Cl, SO 2 CF 3 , CONR 8 R 9 , SO 2 R 10 or COR 11 , wherein the compound of formula VI is preferably three halogens on the aromatic nucleus In the case of an aromatic multinuclear halogenated compound having substituents, all remaining radicals of the groups R 1 ' to R 5' may be hydrogen,
Hal은 Cl 또는 Br이다.Hal is Cl or Br.
본 발명에 따라, 화학식 VIII의 화합물은 화학식 IX의 상응하는 염소화 또는 브롬화 화합물로부터 성공적으로 제조된다.According to the invention, compounds of formula VIII are successfully prepared from the corresponding chlorinated or brominated compounds of formula IX.
상기식에서,In the above formula,
R1'내지 R4'는 동일하거나 상이하고, 수소, F, Cl, Br, I, NO2, CF3, CN, CHO, COF, SO2F, SO2Cl, OCF3, SCF3, SO2CF3, COOR7, CONR8R9, SO2R10, COR11또는 OR12이거나, 서로에 대해 오르토 위치에 존재하고 그룹 R1'내지 R4'로부터 유래하는 2개의 라디칼은 함께 -OC-NR13-CO이고, R7내지 R13은 화학식 I과 동일하고, 화학식 VIII의 화합물이 헤테로방향족 단핵 할로겐화 화합물인 경우 그룹 R1'내지 R4'의 하나 이상의 라디칼은 NO2, CF3, CN, CHO, COOH, COCl, COF, SO2F, SO2Cl, SO2CF3, CONR8R9, SO2R10또는 COR11이며, 화학식 VIII의 화합물이 바람직하게는 방향족 핵상에 3개의 할로겐 치환체를 갖는 헤테로방향족 다핵 할로겐화 화합물인 경우 그룹 R1'내지 R4'의 나머지 라디칼은 모두 수소일 수 있고,R 1 ' to R 4' are the same or different and are hydrogen, F, Cl, Br, I, NO 2 , CF 3 , CN, CHO, COF, SO 2 F, SO 2 Cl, OCF 3 , SCF 3 , SO 2 radicals which are 2 CF 3 , COOR 7 , CONR 8 R 9 , SO 2 R 10 , COR 11 or OR 12, or are in the ortho position with respect to each other and derived from groups R 1 ′ to R 4 ′ together are —OC -NR 13 -CO, R 7 to R 13 are the same as in formula (I), and when the compound of formula (VIII) is a heteroaromatic mononuclear halogenated compound, at least one radical of the groups R 1 ' to R 4' is NO 2 , CF 3 , CN, CHO, COOH, COCl, COF, SO 2 F, SO 2 Cl, SO 2 CF 3 , CONR 8 R 9 , SO 2 R 10 or COR 11 , wherein the compound of formula VIII is preferably In the case of heteroaromatic multinuclear halogenated compounds having halogen substituents, all remaining radicals of groups R 1 ′ to R 4 ′ may be hydrogen,
Hal은 Cl 또는 Br이다.Hal is Cl or Br.
마지막으로, 특히 바람직한 양태에서, 신규한 방법은 또한 화학식 Xa, XIa, XIIa 또는 XIIIa의 상응하는 염소화 또는 브롬화 화합물로부터 화학식 X, XI 및 XII 또는 XIII의 화합물을 제조하는데 사용할 수 있다.Finally, in a particularly preferred embodiment, the novel methods can also be used to prepare compounds of formula (X), (XI) and (XII) or (XIII) from the corresponding chlorinated or brominated compounds of formula (Xa), XIa, XIIa or XIIIa.
상기식에서,In the above formula,
R1'내지 R3'은 동일하거나 상이하고, 수소, F, Cl, Br, I, NO2, CF3, CN, CHO, COF, SO2F, SO2Cl, OCF3, SCF3, SO2CF3, COOR7, CONR8R9, SO2R10, COR11또는 OR12이거나, 가능한 경우 서로에 대해 오르토 위치에 존재하고 그룹 R1'내지 R3'으로부터 유래하는 2개의 라디칼은 함께 -OC-NR13-CO이고, R7내지 R13은 화학식 I과 동일하고,R 1 ' to R 3' are the same or different and are hydrogen, F, Cl, Br, I, NO 2 , CF 3 , CN, CHO, COF, SO 2 F, SO 2 Cl, OCF 3 , SCF 3 , SO 2 radicals which are 2 CF 3 , COOR 7 , CONR 8 R 9 , SO 2 R 10 , COR 11 or OR 12 , if possible, are in the ortho position relative to one another and are derived from groups R 1 ′ to R 3 ′ together -OC-NR 13 -CO, R 7 to R 13 are the same as in formula (I),
Hal은 Cl 또는 Br이다.Hal is Cl or Br.
특히, 질소-함유 헤테로방향족 화합물, 예를 들어 화학식 VIII의 피리딘 유도체의 경우 거대 분자 형성의 구성 성분인 이들 불소화된 방향족 화합물을 성공적으로 제조할 수 있음은 말할 필요도 없으며, 하기 화학식 VIIIa의 화합물과 유사할 수 있다.In particular, it goes without saying that in the case of nitrogen-containing heteroaromatic compounds, for example pyridine derivatives of formula (VIII), these fluorinated aromatic compounds which are components of macromolecular formation can be prepared successfully, May be similar.
상기식에서,In the above formula,
라디칼 R'은 화학식 VIII의 화합물에 대해 제시한 의미와 동일하다.The radical R ′ has the same meanings as given for the compound of formula VIII.
또한, 본 발명의 신규한 방법의 범위내에서 할로겐 치환에 의한 플루오르화는 약 실온 내지, 반응 매질의 비점 및 화학식 I의 화합물에 상응하는 출발 화합물의 비점중 낮은 비점의 온도에서 수행되는 것이 바람직하다. 이러한 문맥에서, 온도는 통상적으로 반응 속도와 관련하여 손실없이 이미 공지된 방법에서보다 낮게 유지시킬 수 있음이 특히 강조되어야 한다.Further, within the scope of the novel process of the present invention, fluorination by halogen substitution is preferably carried out at a temperature of about room temperature to a lower boiling point of the boiling point of the reaction medium and of the starting compound corresponding to the compound of formula (I). . In this context, it should be particularly stressed that the temperature can usually be kept lower than in previously known methods without loss in relation to the reaction rate.
바람직한 양태에서, 신규한 할렉스 방법은 약 40℃ 내지 약 270℃의 온도 범위에서 수행되는 할로겐 치환에 의한 플루오르화로 전형화된다. 특히, 바람직한 변형으로 반응 온도는 약 60℃ 내지 약 220℃의 범위이다.In a preferred embodiment, the novel Halex process is typical of fluorination by halogen substitution carried out in a temperature range of about 40 ° C to about 270 ° C. In particular, in a preferred variant, the reaction temperature is in the range of about 60 ° C to about 220 ° C.
본 발명에 따라 사용될 수 있는 플루오르화 제제는 원칙적으로 Me가 알칼리 금속, 암모늄 또는 포스포늄 또는 암모늄 또는 포스포늄으로부터 유도되는 알킬암모늄 라디칼, 알킬포스포늄 라디칼 또는 아릴포스포늄 라디칼이 포함된다. 불화나트륨, 불화칼륨, 불화세슘, 테트라메틸암모늄 플루오라이드, 및 알킬이 에틸, n-프로필 또는 n-부틸인 다른 테트라알킬암모늄 플루오라이드와 같은 화합물이 편리하다.Fluorinating agents that can be used according to the invention include, in principle, alkylammonium radicals, alkylphosphonium radicals or arylphosphonium radicals in which Me is derived from alkali metals, ammonium or phosphonium or ammonium or phosphonium. Compounds such as sodium fluoride, potassium fluoride, cesium fluoride, tetramethylammonium fluoride, and other tetraalkylammonium fluorides in which the alkyl is ethyl, n-propyl or n-butyl are convenient.
또한, 테트라페닐포스포늄 플루오라이드가 특히 편리하다. 그러나, 불소를 제공하고 본 발명의 범위내에서 성공적으로 사용될 수 있는 화학식 II의 화합물(MeF)중에서 불화인이 가격이 싸기 때문에 특히 바람직하다.Tetraphenylphosphonium fluoride is also particularly convenient. However, phosphorus fluoride is particularly preferred among the compounds of formula II (MeF) which provide fluorine and can be used successfully within the scope of the present invention because of the low cost.
플루오르화 제제는 목적하는 할로겐 치환 수준을 달성하기에 충분한 양으로 사용된다. 이들은 화학식 I의 화합물에 상응하는 출발 화합물의 양을 기준으로 하여 화학양론적으로 사용하는 것이 바람직하다. 또한, 이들은 출발 화합물(들)에서 치환되는 할로겐 원자의 몰량을 기준으로 하여 몰 과량, 특히 바람직하게는 1.1 내지 2.0배 몰과량으로 사용하는 것이 바람직하다.Fluorinated agents are used in amounts sufficient to achieve the desired level of halogen substitution. They are preferably used stoichiometrically based on the amount of starting compound corresponding to the compound of formula (I). Furthermore, they are preferably used in molar excess, particularly preferably 1.1 to 2.0 times molar excess, based on the molar amount of halogen atoms substituted in the starting compound (s).
적당한 경우, 본 발명에 따라 사용되는 반응 매질의 효능(특히, 그 자체로서 높음)은 촉매 효과를 갖는 화합물을 첨가하여 개선시킬 수 있다. 일반적으로, 이러한 목적을 위해 당업자에게 공지된 모든 촉매, 예를 들어 상기 인용된 참조 문헌으로부터의 촉매를 사용할 수 있다. 사용될 수 있는 촉매는 특히 (R'')4N+Hal-(여기서, Hal은 Cl 또는 Br이고, R''은 직쇄 또는 측쇄의 C1-C4-알킬이다); (R''')4P+Hal-(여기서, Hal은 Cl 또는 Br이고, R'''은 직쇄 또는 측쇄의 C1-C4-알킬이다), 또는 아릴, 바람직하게는 페닐; 크라운 에테르; 폴리에틸렌 글리콜 및/또는 피리디늄 염이 포함된다. 본 발명의 방법은 특히 촉매 활성량의 테트라메틸암모늄 클로라이드, 테트라부틸암모늄 클로라이드, 테트라페닐포스포늄 클로라이드, 18-크라운-6, PEG 및/또는 R28R29N-p-피리디늄-R30(여기서, R28내지 R30은 바람직하게는 직쇄 또는 측쇄일 수 있는 탄소수 1 내지 8의 알킬 라디칼이다)을 사용하는 경우 유리한 것으로 밝혀졌다.Where appropriate, the efficacy (especially high per se) of the reaction medium used according to the invention can be improved by the addition of compounds having a catalytic effect. In general, all catalysts known to those skilled in the art can be used for this purpose, for example catalysts from the references cited above. The catalyst which can be used in particular (R '') 4 N + Hal - ( wherein, Hal is Cl or Br, R '' is C 1 -C 4 straight or branched-alkyl); (R ''') 4 P + Hal - wherein Hal is Cl or Br and R''' is straight or branched C 1 -C 4 -alkyl, or aryl, preferably phenyl; Crown ethers; Polyethylene glycol and / or pyridinium salts. The process of the invention particularly relates to catalytically active amounts of tetramethylammonium chloride, tetrabutylammonium chloride, tetraphenylphosphonium chloride, 18-crown-6, PEG and / or R 28 R 29 Np-pyridinium-R 30 , wherein R 28 to R 30 are preferably advantageous when using an alkyl radical having 1 to 8 carbon atoms, which may be straight or branched.
이미 제시한 바와 같이, 플루오르화한 다음 반응 혼합물의 후처리는 반응 혼합물의 분별 증류에 의해 유리하게 수행될 수 있고, 용매를 분리 및 재순환시킬 수 있다. 수성 후처리의 경우, 혼합물을 과량의 물에 부어 넣고, 수득되는 생성물을 여과한 다음 유기 용매로 추출한다.As already indicated, the workup of the reaction mixture after fluorination can be advantageously carried out by fractional distillation of the reaction mixture and the solvent can be separated and recycled. For aqueous workup, the mixture is poured into excess water and the resulting product is filtered and then extracted with an organic solvent.
이러한 맥락에서, 화학식 III 내지 V의 화합물은 디클로로메탄 또는 트리클로로메탄을 사용하여 연속 추출기에서 반응 용액으로부터 연속하여, 간단히 및 완전히 추출할 수 있다.In this context, the compounds of the formulas III to V can be extracted continuously, simply and completely from the reaction solution in a continuous extractor using dichloromethane or trichloromethane.
본 발명에 따른 방법을 사용하는 경우, 필요로 하는 목적 생성물은 특히 고도의 순도로 수득된다. 따라서, 조 생성물의 순도가 90% 이상인 생성물을 원칙적으로 본원에 기술된 방법에 의해 수득할 수 있다. 예를 들면, 거의 어떠한 불순물도 없는 화학식 III 내지 V의 화합물을 추출할 수 있고, 용매를 제거한 후 95% 이상의 순도를 갖는 조 생성물이 수득된다는 것은 놀라운 사실이다.When using the process according to the invention, the desired product in question is obtained in a particularly high degree of purity. Thus, products with a purity of at least 90% of the crude product can in principle be obtained by the methods described herein. For example, it is surprising that the compounds of formulas III to V, which are virtually free of any impurities, can be extracted and a crude product having a purity of at least 95% is obtained after removing the solvent.
또한, 본 발명은 라디칼 R1내지 R6중의 하나가 Cl 또는 Br인 화학식 I의 화합물을 화학식 II의 플루오라이드와 반응시킴으로써 화학식 I의 플루오르화 방향족 화합물을 제조하는 경우 출발 물질에 대한 반응 매질, 희석제 또는 용매, 또는 이러한 매질, 희석제 또는 용매에 대한 첨가제로서 화학식 III의 1-알킬-2,3-디하이드로-1H-포스폴-1-옥사이드, 화학식 IV의 1-알킬-2,5-디하이드로-1H-포스폴-1-옥사이드 및/또는 화학식 V의 1-알킬-포스폴란-1-옥사이드의 용도에 관한 것이다.The present invention also relates to the reaction medium for the starting materials, diluents when the fluorinated aromatic compounds of formula (I) are prepared by reacting a compound of formula (I) wherein one of the radicals R 1 to R 6 is Cl or Br with a fluoride of formula (II) Or 1-alkyl-2,3-dihydro-1H-phosphol-1-oxide of formula (III), 1-alkyl-2,5-dihydro of formula (IV) as a solvent or additive to such a medium, diluent or solvent And to the use of 1-alkyl-phospholan-1-oxide of formula (V).
화학식 IFormula I
화학식 IIFormula II
MeFMeF
화학식 IIIFormula III
화학식 IVFormula IV
화학식 VFormula V
상기식에서,In the above formula,
W는 N 또는 CR3이고,W is N or CR 3 ,
X는 N 또는 CR4이며,X is N or CR 4 ,
Y는 N 또는 CR5이고,Y is N or CR 5 ,
Z는 N 또는 CR6이며,Z is N or CR 6 ,
R1, R2, R3, R4, R5및 R6은 동일하거나 상이하고, 수소, F, Cl, Br, I, NO2, CF3, CN, CHO, COF, SO2F, SO2Cl, OCF3, SCF3, SO2CF3, COOR7, CONR8R9, SO2R10, COR11또는 OR12이거나, 서로에 대해 오르토 위치에 존재하고 그룹 R1내지 R6로부터 유래하는 2개의 라디칼은 함께 -OC-NR13-CO-이고,R 1 , R 2 , R 3 , R 4 , R 5 and R 6 are the same or different and hydrogen, F, Cl, Br, I, NO 2 , CF 3 , CN, CHO, COF, SO 2 F, SO 2 Cl, OCF 3 , SCF 3 , SO 2 CF 3 , COOR 7 , CONR 8 R 9 , SO 2 R 10 , COR 11 or OR 12, or are in the ortho position relative to one another and derived from groups R 1 to R 6 The two radicals together are —OC—NR 13 —CO—,
R7, R8, R9, R10, R11, R12및 R13은 동일하거나 상이하고, 서로 독립적으로 수소, 직쇄 또는 측쇄의 C1내지 C6-알킬, 아릴, 바람직하게는 페닐, 또는 아릴알킬이고, 알킬 라디칼 및 아릴알킬 라디칼은 적합한 경우 할로겐에 의해 3회 이하로 치환될 수 있으며, 바람직하게는 CF3및 CHalXH3-X이며,R 7 , R 8 , R 9 , R 10 , R 11 , R 12 and R 13 are the same or different and independently from each other hydrogen, straight or branched C 1 to C 6 -alkyl, aryl, preferably phenyl, Or arylalkyl, the alkyl radical and the arylalkyl radical may be substituted up to three times by halogen if appropriate, preferably CF 3 and CHal X H 3-X ,
라디칼 R1내지 R13중의 2개 이상은 적합한 경우 서로 연결되어 하나 이상의 3 내지 7원 환을 형성하고,Two or more of the radicals R 1 to R 13 are suitably linked to one another to form one or more three to seven membered rings,
단, (i) W, X 및 Y는 동시에 N이 아니고;Provided that (i) W, X and Y are not N at the same time;
(ii) 라디칼 R1내지 R6중의 하나 이상은 불소이어야 하며;(ii) at least one of the radicals R 1 to R 6 must be fluorine;
(iii) a) 화학식 I의 화합물이 방향족 단핵 할로겐화 화합물인 경우, 그룹 R1내지 R6의 나머지 라디칼중 하나 이상은 NO2, CF3, CN, CHO, COOH, COCl, COF, SO2F, SO2Cl, SO2CF3, CONR8R9, SO2R10또는 COR11이고;(iii) a) when the compound of formula (I) is an aromatic mononuclear halogenated compound, at least one of the remaining radicals of groups R 1 to R 6 is NO 2 , CF 3 , CN, CHO, COOH, COCl, COF, SO 2 F, SO 2 Cl, SO 2 CF 3 , CONR 8 R 9 , SO 2 R 10 or COR 11 ;
b) 화학식 I의 화합물이 바람직하게는 방향족 핵상에 3개의 할로겐 치환체를 갖는 방향족 다핵 할로겐화 화합물인 경우, 그룹 R1내지 R6의 나머지 라디칼은 모두 수소일 수 있으며;b) when the compound of formula (I) is preferably an aromatic multinuclear halogenated compound having three halogen substituents on the aromatic nucleus, all remaining radicals of groups R 1 to R 6 may be hydrogen;
Me는 Na, K, Cs, Rb, N(R14)4또는 P(R15)4이고,Me is Na, K, Cs, Rb, N (R 14 ) 4 or P (R 15 ) 4 ,
4개의 라디칼 R14는 서로 독립적으로 동일하거나 상이할 수 있고, 수소 또는 직쇄 또는 측쇄의 C1내지 C8-알킬(여기서, 알킬 라디칼은 예를 들어 방향족 라디칼에 의해 치환될 수 있다)이며, 4개의 라디칼 R15는 서로 독립적으로 동일하거나 상이할 수 있고, R14와 동일하거나 페닐일 수 있으며,The four radicals R 14 may be the same or different independently of one another and are hydrogen or straight or branched C 1 to C 8 -alkyl, wherein the alkyl radicals may for example be substituted by aromatic radicals, 4 Radicals R 15 may be independently the same or different from each other, may be the same as R 14 or be phenyl,
R16은 직쇄 또는 측쇄의 탄소수 1 내지 8의 알킬 라디칼, 페닐, 벤질, 사이클로알킬, OR25또는 NR26R27(여기서, R25내지 R27은 서로 독립적으로 동일하거나 상이하고, 직쇄 또는 측쇄의 탄소수 1 내지 4의 알킬 라디칼이다)이고,R 16 is straight or branched alkyl radical of 1 to 8 carbon atoms, phenyl, benzyl, cycloalkyl, OR 25 or NR 26 R 27 , wherein R 25 to R 27 are the same as or different from each other independently and are linear or branched Is an alkyl radical having 1 to 4 carbon atoms),
R17, R18, R19, R20, R21, R22, R23및 R24는 서로 독립적으로 동일하거나 상이하고, 수소, 페닐 또는 직쇄 또는 측쇄의 C1-8-알킬 라디칼이다.R 17 , R 18 , R 19 , R 20 , R 21 , R 22 , R 23 and R 24 are independently the same or different from each other and are hydrogen, phenyl or straight or branched C 1-8 -alkyl radicals.
이러한 맥락에서, 어떠한 추가의 희석제 또는 용매를 첨가하지 않고서 반응 매질에서뿐만 아니라 반응 매질 자체로서 화학식 III 내지 V의 화합물을 사용하는 것이 특히 매우 바람직하다.In this context, particular preference is given to using compounds of the formulas III to V in the reaction medium as well as the reaction medium itself without the addition of any further diluents or solvents.
하기 실시예는 본 발명의 대상을 설명하기 위해 사용된다.The following examples are used to illustrate the subject matter of the present invention.
실시예 1 내지 14 및 비교 실시예 1 내지 12aExamples 1-14 and Comparative Examples 1-12a
용매 50ml중의 유기 기제 1.0mol을 온도계 및 버블 계수기가 장착된 3목 플라스크에 초기에 도입하고, 0.12 내지 0.2mol의 불화칼륨 KF(각 염소 원자에 대해)을 습기 부재(N2)하에 가한다. 반응 혼합물을 특정한 온도에서 특정한 시간 동안 가열한다(하기 표 1 참조). 샘플을 반응 혼합물로부터 가끔 취하고, 반응 진행 및 기체 크로마토그래피에 의해 전환 수준을 모니터하기 위해 사용한다. 반응 혼합물은 출발 화합물이 더이상 검출되지 않을 때까지 후처리한다.1.0 mol of organic base in 50 ml of solvent is initially introduced into a three necked flask equipped with a thermometer and bubble counter, and 0.12 to 0.2 mol of potassium fluoride KF (for each chlorine atom) is added in the absence of moisture (N 2 ). The reaction mixture is heated at a certain temperature for a certain time (see Table 1 below). Samples are occasionally taken from the reaction mixture and used to monitor the conversion level by reaction progress and gas chromatography. The reaction mixture is worked up until the starting compound is no longer detected.
후처리하는 동안, 반응 혼합물을 과량의 물에 부어 넣고, 고체 성분을 여과하며, 적합한 경우 CH2Cl2로 추출하여 액체 생성물을 분리하고, 물로 세척하여 건조한다. 수득된 생성 혼합물은 GC, GCMS 및19F NMR에 의해 분석할 수 있다. 생성물은 적합한 용매로부터의 재결정화 또는 대기압 또는 감압하에서의 분별 증류에 의해 추가로 정제한다.During workup, the reaction mixture is poured into excess water, the solid components are filtered off and, if appropriate, extracted with CH 2 Cl 2 to separate the liquid product, washed with water and dried. The resulting mixture can be analyzed by GC, GCMS and 19 F NMR. The product is further purified by recrystallization from a suitable solvent or fractional distillation under atmospheric or reduced pressure.
하기 표 1은 실시예에 사용된 기제, 할로겐 치환에 의한 플루오르화에 사용된 반응 매질, 기타 반응 조건, 전환 수준 및 총 생성물 수율의 개관을 제공한다.Table 1 below provides an overview of the base used in the examples, the reaction medium used for fluorination by halogen substitution, other reaction conditions, conversion levels and total product yield.
실시예 15Example 15
1-메틸-2,3-디하이드로-1H-포스폴-1-옥사이드의 존재하에 2,4,6-트리클로로피리미딘의 반응에 의한 2,4,6-트리플루오로피리미딘의 제조방법Process for preparing 2,4,6-trifluoropyrimidine by reaction of 2,4,6-trichloropyrimidine in the presence of 1-methyl-2,3-dihydro-1H-phosphol-1-oxide
2,4,6-트리클로로피리미딘 183g(1mol), KF 228g(4mol) 및 1-메틸-2,3-디하이드로-1H-포스폴-1-옥사이드 20g(0.17mol) 및 설폴란 400ml를 온도계, 교반기 및 버블 계수기를 갖는 환류 콘덴서가 장착된 1.5L 4-목 플라스크에 초기에 도입한다. 이어서, 혼합물을 교반하에 100℃에서 3시간 동안 가열한다. 반응을 종결시킨 후, 생성물 (2,4,6-트리플루오로피리미딘)을 감압하에 용기 플라스크에서 증류하고, 증류에 의해 연속적으로 정제한다. 전환: 100%, 수율: 127g(이론치의 95%).183 g (1 mol) of 2,4,6-trichloropyrimidine, 228 g (4 mol) of KF and 20 g (0.17 mol) of 1-methyl-2,3-dihydro-1H-phospho-1-oxide and 400 ml of sulfolane It is initially introduced into a 1.5 L four-necked flask equipped with a reflux condenser with thermometer, stirrer and bubble counter. The mixture is then heated at 100 ° C. for 3 hours with stirring. After completion of the reaction, the product (2,4,6-trifluoropyrimidine) is distilled off in a vessel flask under reduced pressure and purified continuously by distillation. Conversion: 100%, yield: 127 g (95% of theory).
비교실시예 13Comparative Example 13
설폴란 용액중의 KF와 2,4,6-트리클로로피리미딘의 반응에 의한 2,4,6-트리플루오로피리미딘의 제조방법Method for preparing 2,4,6-trifluoropyrimidine by reaction of KF and 2,4,6-trichloropyrimidine in sulfolane solution
2,4,6-트리클로로피리미딘 183g(1mol), KF 228g(4mol) 및 설폴란 400ml를 사용하고, 반응을 실시예 15에 기술된 바와 같이 수행한다. 전환율(2,4,6-트리플루오로피리미딘을 기준으로)은 42%(수율 35%)이다.183 g (1 mol) of 2,4,6-trichloropyrimidine, 228 g (4 mol) of KF and 400 ml of sulfolane are used and the reaction is carried out as described in Example 15. The conversion (based on 2,4,6-trifluoropyrimidine) is 42% (yield 35%).
본 발명의 추가의 잇점 및 양태는 하기 청구의 범위로부터 판명된다.Further advantages and aspects of the invention emerge from the following claims.
Claims (12)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19608791.0 | 1996-03-07 | ||
| DE19608791A DE19608791A1 (en) | 1996-03-07 | 1996-03-07 | Process for the preparation of fluorinated aromatics and fluorinated nitrogen-containing heteroaromatics |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR19990087687A true KR19990087687A (en) | 1999-12-27 |
Family
ID=7787475
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1019980707152A Withdrawn KR19990087687A (en) | 1996-03-07 | 1997-02-28 | Process for preparing fluorinated aromatics and fluorinated nitrogen-containing hetero-aromatics |
Country Status (7)
| Country | Link |
|---|---|
| EP (1) | EP0885179A1 (en) |
| JP (1) | JP2000506149A (en) |
| KR (1) | KR19990087687A (en) |
| CN (1) | CN1212674A (en) |
| CA (1) | CA2248294A1 (en) |
| DE (1) | DE19608791A1 (en) |
| WO (1) | WO1997032832A1 (en) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1998022413A1 (en) * | 1996-11-22 | 1998-05-28 | Albemarle Corporation | Halogen exchange reactions and uses thereof |
| DE19934594A1 (en) * | 1999-07-23 | 2001-01-25 | Clariant Gmbh | Mixtures containing tetrakis (pyrrolidino / piperidino) phosphonium salts |
| ATE485275T1 (en) | 2002-02-12 | 2010-11-15 | Glaxosmithkline Llc | NICOTINAMIDES AND THEIR USE AS P38 INHIBITORS |
| GB0308201D0 (en) | 2003-04-09 | 2003-05-14 | Smithkline Beecham Corp | Novel compounds |
| DE102004033525A1 (en) * | 2004-07-08 | 2006-02-02 | Lanxess Deutschland Gmbh | Improved process for the production of ring-fluorinated aromatics |
| HUE045511T2 (en) | 2014-02-03 | 2020-01-28 | Vitae Pharmaceuticals Llc | Dihydropyrrolopyridine inhibitors of ror-gamma |
| ES2715458T7 (en) | 2014-10-14 | 2020-05-28 | Vitae Pharmaceuticals Llc | ROR-gamma dihydropyrrolopyridine inhibitors |
| US9845308B2 (en) | 2014-11-05 | 2017-12-19 | Vitae Pharmaceuticals, Inc. | Isoindoline inhibitors of ROR-gamma |
| US9663515B2 (en) | 2014-11-05 | 2017-05-30 | Vitae Pharmaceuticals, Inc. | Dihydropyrrolopyridine inhibitors of ROR-gamma |
| EP3331876B1 (en) | 2015-08-05 | 2020-10-07 | Vitae Pharmaceuticals, LLC | Modulators of ror-gamma |
| MA53943A (en) | 2015-11-20 | 2021-08-25 | Vitae Pharmaceuticals Llc | ROR-GAMMA MODULATORS |
| TWI757266B (en) | 2016-01-29 | 2022-03-11 | 美商維它藥物有限責任公司 | Modulators of ror-gamma |
| US9481674B1 (en) | 2016-06-10 | 2016-11-01 | Vitae Pharmaceuticals, Inc. | Dihydropyrrolopyridine inhibitors of ROR-gamma |
| WO2019018975A1 (en) | 2017-07-24 | 2019-01-31 | Vitae Pharmaceuticals, Inc. | Inhibitors of ror gamma |
| WO2019023207A1 (en) | 2017-07-24 | 2019-01-31 | Vitae Pharmaceuticals, Inc. | INHIBITORS OF RORƳ |
| CN115745766B (en) * | 2022-10-27 | 2024-05-14 | 兰州康鹏威耳化工有限公司 | Preparation method of trifluorobenzaldehyde and trifluorobenzyl bromide |
| CN115611717B (en) * | 2022-11-01 | 2024-06-28 | 上海万溯药业有限公司 | Preparation method of polyfluorobenzaldehyde |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2525442C3 (en) * | 1975-06-07 | 1978-04-13 | Bayer Ag, 5090 Leverkusen | Process for the preparation of geminal dihalides |
| ES2083631T3 (en) * | 1991-07-17 | 1996-04-16 | Hoechst Ag | PROCEDURE FOR THE PREPARATION OF CHLOROFLUORONITROBENZENES. |
| US5315043A (en) * | 1992-02-05 | 1994-05-24 | E. I. Du Pont De Nemours And Company | Aromatic nucleophilic fluorination |
-
1996
- 1996-03-07 DE DE19608791A patent/DE19608791A1/en not_active Withdrawn
-
1997
- 1997-02-28 KR KR1019980707152A patent/KR19990087687A/en not_active Withdrawn
- 1997-02-28 CA CA002248294A patent/CA2248294A1/en not_active Abandoned
- 1997-02-28 EP EP97905116A patent/EP0885179A1/en not_active Withdrawn
- 1997-02-28 JP JP9531421A patent/JP2000506149A/en active Pending
- 1997-02-28 CN CN97192773A patent/CN1212674A/en active Pending
- 1997-02-28 WO PCT/EP1997/000970 patent/WO1997032832A1/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| EP0885179A1 (en) | 1998-12-23 |
| WO1997032832A1 (en) | 1997-09-12 |
| DE19608791A1 (en) | 1997-09-11 |
| CA2248294A1 (en) | 1997-09-12 |
| JP2000506149A (en) | 2000-05-23 |
| CN1212674A (en) | 1999-03-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR19990087687A (en) | Process for preparing fluorinated aromatics and fluorinated nitrogen-containing hetero-aromatics | |
| US4226811A (en) | Preparation of substituted fluorobenzenes | |
| JP2008044944A (en) | Use of composition of ionic nature as substrate reagent, composition constituting fluorination reagent, and method using the same | |
| EP0018606A1 (en) | Direct fluorination of etherified hydroxy group-bearing aromatic compounds | |
| US7247733B2 (en) | Process for preparing nuclear-fluorinated aromatics | |
| JP5426880B2 (en) | Process for producing 5-fluoro-1,3-dialkyl-1H-pyrazole-4-carbonyl fluoride | |
| JP2006022105A (en) | Improved method for producing fluorine-containing aromatic ring | |
| JPH0788350B2 (en) | Method for producing N-fluorosulfonamide | |
| JP2577567B2 (en) | Method for producing aromatic fluorine compound | |
| US4727187A (en) | Process for the preparation of α, α-difluoroalkyl phenyl ether derivatives | |
| US5756834A (en) | Process for preparing fluorinated aromatics | |
| US4351777A (en) | Preparation of fluorobenzonitriles | |
| Van der Puy | Potassium fluoride catalyzed fluorodesulfonylations of aryl sulfonyl fluorides | |
| US5502260A (en) | Process for preparing multiply fluorinated nitrobenzenes | |
| KR20000017260A (en) | Process for Preparing Fluorinated Benzyl Alcohols and Benzaldehydes | |
| US4456772A (en) | Process for the preparation of optionally substituted fluoro-nitro-benzaldehydes | |
| JPH04224528A (en) | Method for production of fluorine containing ethane derivative, catalytic mixture and fluorinated hydrocarbon solution | |
| JPH024580B2 (en) | ||
| US5476976A (en) | Process for preparing fluoronitrobenzenes | |
| JPH0853399A (en) | Preparation of aromatic fluorinated compound and new diamide | |
| JP4804762B2 (en) | Method for producing fluorohalogen ether | |
| US6274739B1 (en) | Method for producing chlorobenzoxazolene | |
| US4330366A (en) | Process for the preparation of halogenated benzoyl fluorides | |
| JPS6094919A (en) | Production of organic fluoride | |
| JPS6350339B2 (en) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PA0105 | International application |
Patent event date: 19980907 Patent event code: PA01051R01D Comment text: International Patent Application |
|
| N231 | Notification of change of applicant | ||
| PN2301 | Change of applicant |
Patent event date: 19981014 Comment text: Notification of Change of Applicant Patent event code: PN23011R01D |
|
| PG1501 | Laying open of application | ||
| PC1203 | Withdrawal of no request for examination | ||
| WITN | Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid |